Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Calcimedica Ord Shs (CALC)  
$0.44 0.00 (0.00%) as of 4:30 Fri 3/17


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 5,660,000
Market Cap: 2.49(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4404 - $0.4404
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Graybug Vision is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. Co.'s product candidate, GB-102, is an intravitreal injection of a microparticle depot formulation of sunitinib, a potent inhibitor of neovascular growth and permeability, which are causes of retinal disease. Co.'s second product candidate, GB-401, is an intravitreally administered, proprietary implant formulation containing a prodrug of a beta-adrenergic receptor inhibitor developed to provide a controlled release of the active drug to maintain reduced intraocular pressure, for six months or longer after a single injection.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 4,000 1,363,274 1,505,415 1,505,415
Total Buy Value $15,600 $5,047,430 $5,493,543 $5,493,543
Total People Bought 1 4 7 7
Total Buy Transactions 2 6 58 58
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 131
  Page 4 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Valence Investments Spv Vi, Llc 10% Owner   –       –       •   2023-03-20 4 A $0.00 $0 D/D 356,989 356,989     -
   Roberts Eric W Chief Business Officer   •       •       •   2023-03-20 4 A $0.00 $0 I/I 749,987 10,661     -
   Leheny A. Rachel Chief Executive Officer   •       •       •   2023-03-20 4 A $0.00 $0 I/I 739,326 316,109     -
   Stauderman Kenneth A. Chief Scientific Officer   •       –      –    2023-03-20 4 A $0.00 $0 D/D 11,944 11,944     -
   Middleton Fred A Director   –       •       •   2023-03-20 4 A $0.00 $0 I/I 1,648,220 8,176     -
   Wilson Robert N Director   –       •      –    2023-03-20 4 A $0.00 $0 D/D 181,655 181,655     -
   Guerard Frederic Chief Executive Officer   •       •      –    2023-03-03 4 D $0.57 $50,926 D/D (89,344) 383,682     -
   Guerard Frederic Chief Executive Officer   •       •      –    2023-03-03 4 OE $0.00 $0 D/D 315,496 473,026     -
   Breuil Robert S Chief Financial Officer   •       –      –    2023-03-03 4 D $0.57 $28,177 D/D (49,434) 158,849     -
   Breuil Robert S Chief Financial Officer   •       –      –    2023-03-03 4 OE $0.00 $0 D/D 121,217 208,283     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2023-03-03 4 D $0.57 $24,450 D/D (42,894) 135,338     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2023-03-03 4 OE $0.00 $0 D/D 120,655 178,232     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-12-12 4 D $0.58 $1,003 D/D (1,729) 87,066     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-12-12 4 OE $0.00 $0 D/D 5,000 88,795     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2022-12-01 4 D $0.63 $1,734 D/D (2,752) 57,577     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2022-12-01 4 OE $0.00 $0 D/D 9,375 60,329     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-12-01 4 D $0.63 $2,165 D/D (3,437) 83,795     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-12-01 4 OE $0.00 $0 D/D 9,938 87,232     -
   Guerard Frederic Chief Executive Officer   •       •      –    2022-12-01 4 D $0.63 $6,973 D/D (11,068) 157,530     -
   Guerard Frederic Chief Executive Officer   •       •      –    2022-12-01 4 OE $0.00 $0 D/D 28,125 168,598     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2022-11-24 4 D $0.67 $5,531 D/D (8,255) 50,954     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2022-11-24 4 OE $0.00 $0 D/D 28,125 59,209     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-11-24 4 D $0.67 $6,516 D/D (9,726) 77,294     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-11-24 4 OE $0.00 $0 D/D 28,125 87,020     -
   Guerard Frederic Chief Executive Officer   •       •      –    2022-11-24 4 D $0.67 $17,302 D/D (25,824) 140,473     -
  131 Records found
  1  2  3  4  5  6   
  Page 4 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us